THE ROLE OF NEDD4-1 IN IGF-1R SIGNALING
NEDD4-1 在 IGF-1R 信号转导中的作用
基本信息
- 批准号:8316173
- 负责人:
- 金额:$ 32.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-08-08 至 2016-05-31
- 项目状态:已结题
- 来源:
- 关键词:BindingBiological MarkersCancer Cell GrowthCancer PatientCell ProliferationCell SurvivalCell physiologyCellsClinical TrialsCultured CellsDNADataDevelopmentDrug Delivery SystemsEmbryonic DevelopmentFc ReceptorGoalsGrowthGuidelinesHumanInsulin-Like Growth Factor IKnock-outKnowledgeLigaseMaintenanceMalignant NeoplasmsMetabolismModelingMolecularMusOncogenicOutcomePTEN genePhosphorylationPlayProteinsReceptor InhibitionReceptor SignalingRegulationResearchRoleSS DNA BPScreening procedureSignal PathwaySignal TransductionTestingUbiquitinationWorkXenograft Modelbasecancer cellcancer therapycell growthimprovedinsightnew therapeutic targetnovelnovel strategiesoverexpressionprotein expressionreceptorreplication factor Aresponsetreatment planningtumortumorigenesis
项目摘要
DESCRIPTION (provided by applicant): NEDD4-1 is an E3 ubiquitination ligase that is frequently over-expressed in human cancers. NEDD4-1 plays an important role in tumorigenesis. Although it has been suggested that NEDD4-1 functions as an oncogenic protein by facilitation of Akt activation, the molecular mechanisms by which NEDD4-1 activates Akt remain largely unknown. We found that NEDD4-1 activates Akt via regulation of IGF-1R signaling. Strikingly, we also found that activation of Akt by NEDD4-1 is negatively regulated by replication protein A (RPA), a single strand DNA (ssDNA) binding protein which is generally believed to play a critical role in DNA metabolism. Thus, we are proposing a study to test the central hypothesis that NEDD4-1 plays a role in cell proliferation via activation of IGF-1R signaling and this pathway is inhibited by RPA. Therefore, growth of cells overexpressing NEDD4-1 is specifically suppressed by IGF-1R inhibition through IGF-1R antibody and/or RPA. Three interrelated specific aims are proposed to test our hypothesis. Aim 1 will identify the role of NEDD4-1 in cell proliferation via regulation of IGF-1R signaling. Aim 2 will delineate how NEDD4-1 dependent IGF-1R signaling is regulated by RPA. Aim 3 will determine the antitumor activity of blocking IGF-1R signaling in cells over-expressing NEDD4-1. We anticipate to (1) define the molecular mechanisms by which NEDD4-1 promotes cell proliferation via regulation of IGF-1R signaling; (2) identify a novel function of RPA in suppression of IGF-1R signaling via interaction with NEDD4-1; (3) find that the growth of cancer cells over-expressing NEDD4-1 can be specifically targeted by IGF-1R inhibition through RPA and/or IGF-1R antibody. The expected results will fundamentally advance our understanding of the molecular mechanism underlying NEDD4-1 associated cancer development. In addition, identification of a novel function of RPA in suppression of IGF-1R signaling will facilitate the development of novel drugs targeting NEDD4-1 or IGF-1R. Moreover, the expected result will improve guidance for cancer treatment plans based on better predictions of tumor response to IGR-1R inhibition by identification of cancer patients with NEDD4-1 over-expression.
描述(申请人提供):NEDD4-1是一种E3泛素化连接酶,在人类癌症中经常过度表达。NEDD4-1在肿瘤发生中起重要作用。尽管已有研究表明NEDD4-1通过促进Akt的激活而发挥致癌蛋白的作用,但NEDD4-1激活Akt的分子机制仍不清楚。我们发现NEDD4-1通过调节IGF-1R信号激活Akt。值得注意的是,我们还发现NEDD4-1对Akt的激活受到复制蛋白A(RPA)的负调控,复制蛋白A是一种单链DNA(SsDNA)结合蛋白,通常被认为在DNA代谢中发挥关键作用。因此,我们建议进行一项研究来检验中心假设,即NEDD4-1通过激活IGF-1R信号而在细胞增殖中发挥作用,并且这一途径被RPA抑制。因此,IGF-1R通过IGF-1R抗体和/或RPA特异性地抑制过表达NEDD4-1的细胞的生长。为了检验我们的假设,本文提出了三个相互关联的具体目标。目的1研究NEDD4-1通过调节IGF-1R信号通路在细胞增殖中的作用。AIM 2将描述RPA如何调节NEDD4-1依赖的IGF-1R信号。目的3确定在过表达NEDD4-1的细胞中阻断IGF-1R信号转导的抗肿瘤活性。我们期望(1)确定NEDD4-1通过调节IGF-1R信号促进细胞增殖的分子机制;(2)确定RPA通过与NEDD4-1相互作用抑制IGF-1R信号的新功能;(3)发现通过RPA和/或IGF-1R抗体抑制过表达NEDD4-1的癌细胞的生长可以被IGF-1R特异性靶向。预期的结果将从根本上促进我们对NEDD4-1相关癌症发生的分子机制的理解。此外,发现RPA在抑制IGF-1R信号转导中的新功能将有助于开发针对NEDD4-1或IGF-1R的新药。此外,预期结果将通过识别NEDD4-1过表达的癌症患者来更好地预测肿瘤对IGR-1R抑制的反应,从而改进对癌症治疗计划的指导。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Junran Zhang其他文献
Junran Zhang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Junran Zhang', 18)}}的其他基金
Targeting cholesterol metabolism and replication stress response in cancer therapy
癌症治疗中针对胆固醇代谢和复制应激反应
- 批准号:
10328961 - 财政年份:2021
- 资助金额:
$ 32.58万 - 项目类别:
Targeting cholesterol metabolism and replication stress response in cancer therapy
癌症治疗中针对胆固醇代谢和复制应激反应
- 批准号:
10548830 - 财政年份:2021
- 资助金额:
$ 32.58万 - 项目类别:
B55 alpha deficiency as a therapeutic target in cancer
B55 α 缺乏症作为癌症的治疗靶点
- 批准号:
9981116 - 财政年份:2020
- 资助金额:
$ 32.58万 - 项目类别:
Interruption of cholesterol metabolism and replication stress response in cancer therapy
癌症治疗中胆固醇代谢和复制应激反应的中断
- 批准号:
10044013 - 财政年份:2020
- 资助金额:
$ 32.58万 - 项目类别:
B55 alpha deficiency as a therapeutic target in cancer
B55 α 缺乏症作为癌症的治疗靶点
- 批准号:
10162546 - 财政年份:2020
- 资助金额:
$ 32.58万 - 项目类别:
B55 alpha deficiency as a therapeutic target in cancer
B55 α 缺乏症作为癌症的治疗靶点
- 批准号:
10659238 - 财政年份:2020
- 资助金额:
$ 32.58万 - 项目类别:
Interruption of squalene epoxidase and DNA damage response in cancer therapy
癌症治疗中角鲨烯环氧酶和 DNA 损伤反应的中断
- 批准号:
10066331 - 财政年份:2019
- 资助金额:
$ 32.58万 - 项目类别:
THE ROLE OF NEDD4-1 IN IGF-1R SIGNALING
NEDD4-1 在 IGF-1R 信号转导中的作用
- 批准号:
8693962 - 财政年份:2011
- 资助金额:
$ 32.58万 - 项目类别:
THE ROLE OF NEDD4-1 IN IGF-1R SIGNALING
NEDD4-1 在 IGF-1R 信号转导中的作用
- 批准号:
8847292 - 财政年份:2011
- 资助金额:
$ 32.58万 - 项目类别:
THE ROLE OF NEDD4-1 IN IGF-1R SIGNALING
NEDD4-1 在 IGF-1R 信号转导中的作用
- 批准号:
8446564 - 财政年份:2011
- 资助金额:
$ 32.58万 - 项目类别:
相似海外基金
MRI and Biological Markers of Acute E-Cigarette Exposure in Smokers and Vapers
吸烟者和电子烟使用者急性电子烟暴露的 MRI 和生物标志物
- 批准号:
10490338 - 财政年份:2021
- 资助金额:
$ 32.58万 - 项目类别:
MRI and Biological Markers of Acute E-Cigarette Exposure in Smokers and Vapers
吸烟者和电子烟使用者急性电子烟暴露的 MRI 和生物标志物
- 批准号:
10353104 - 财政年份:2021
- 资助金额:
$ 32.58万 - 项目类别:
Investigating pollution dynamics of swimming pool waters by means of chemical and biological markers
利用化学和生物标记物研究游泳池水体的污染动态
- 批准号:
21K04320 - 财政年份:2021
- 资助金额:
$ 32.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
MRI and Biological Markers of Acute E-Cigarette Exposure in Smokers and Vapers
吸烟者和电子烟使用者急性电子烟暴露的 MRI 和生物标志物
- 批准号:
10688286 - 财政年份:2021
- 资助金额:
$ 32.58万 - 项目类别:
Novel biological markers for immunotherapy and comprehensive genetic analysis in thymic carcinoma
用于胸腺癌免疫治疗和综合遗传分析的新型生物标志物
- 批准号:
20K17755 - 财政年份:2020
- 资助金额:
$ 32.58万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Examination of Biological Markers Associated with Neurobehavioral and Neuropsychological Outcomes in Military Veterans with a History of Traumatic Brain Injury
与有脑外伤史的退伍军人的神经行为和神经心理结果相关的生物标志物的检查
- 批准号:
10578649 - 财政年份:2019
- 资助金额:
$ 32.58万 - 项目类别:
Examination of Biological Markers Associated with Neurobehavioral and Neuropsychological Outcomes in Military Veterans with a History of Traumatic Brain Injury
与有脑外伤史的退伍军人的神经行为和神经心理结果相关的生物标志物的检查
- 批准号:
10295141 - 财政年份:2019
- 资助金额:
$ 32.58万 - 项目类别:
Examination of Biological Markers Associated with Neurobehavioral and Neuropsychological Outcomes in Military Veterans with a History of Traumatic Brain Injury
与有脑外伤史的退伍军人的神经行为和神经心理结果相关的生物标志物的检查
- 批准号:
10041708 - 财政年份:2019
- 资助金额:
$ 32.58万 - 项目类别:
Examination of Biological Markers Associated with Neurobehavioral and Neuropsychological Outcomes in Military Veterans with a History of Traumatic Brain Injury
与有脑外伤史的退伍军人的神经行为和神经心理结果相关的生物标志物的检查
- 批准号:
9776149 - 财政年份:2019
- 资助金额:
$ 32.58万 - 项目类别:
Combining biological and non-biological markers to develop a model predictive of treatment response for individuals with depression
结合生物和非生物标志物来开发预测抑郁症患者治疗反应的模型
- 批准号:
2063934 - 财政年份:2018
- 资助金额:
$ 32.58万 - 项目类别:
Studentship